Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods and compositions for increasing N-acetylglucosaminidase (NAGLU) activity in the CNS using a fusion antibody comprising an anti-human insulin receptor antibody and NAGLU

Methods and compositions for increasing N-acetylglucosaminidase (NAGLU) activity in the CNS using a fusion antibody comprising an anti-human insulin receptor antibody and NAGLU

US Patent 10538589 · Granted Jan 21, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods and compositions for increasing iduronate 2-sulfatase activity in the CN2024
Methods and compositions for increasing iduronate 2-sulfatase activity in the CN2024
Methods and compositions for increasing alpha-L-iduronidase activity in the CNS2022
Methods and compositions for increasing alpha-L-iduronidase activity in the CNS2022
Macromolecular compositions that cross the blood-brain barrier and methods of us2021
Macromolecular compositions that cross the blood-brain barrier and methods of us2021
Methods and compositions for increasing iduronate 2-sulfatase activity in the CN2021
Methods and compositions for increasing iduronate 2-sulfatase activity in the CN2021
Compositions and methods related to structures that cross the blood brain barrie2021
Compositions and methods related to structures that cross the blood brain barrie2021
Methods and compositions for increasing α-L-iduronidase activity in the CNS2019
Methods and compositions for increasing α-L-iduronidase activity in the CNS2019